Publication | Closed Access

Molecular docking simulation and anticancer assessment on human breast carcinoma cell line using novel bis(1,4-dihydropyrano[2,3- c ]pyrazole-5-carbonitrile) and bis(1,4-dihydropyrazolo[4′,3′:5,6]pyrano[2,3- b ]pyridine-6-carbonitrile) derivatives

Molecular DockingMedicinal ChemistryPharmaceutical ChemistryMolecular ModelingPolymer-drug ConjugateMedicineNatural SciencesAnticancer AssessmentNovel BisBreast CancerMolecular OncologyAnti-cancer AgentTumor TargetingPharmacologyRadiation OncologyCancer ResearchSmall MoleculesDrug Discovery